Wednesday, December 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Lululemon Shares Tumble as Growth Forecast Slashed

Andreas Sommer by Andreas Sommer
September 9, 2025
in Analysis, Consumer & Luxury, Earnings
0
Lululemon Stock
0
SHARES
172
VIEWS
Share on FacebookShare on Twitter

The athletic apparel retailer Lululemon, once a darling of the sector, is facing significant headwinds. A stark downward revision of its full-year guidance has rattled investor confidence, revealing deep-seated operational challenges within its crucial North American business. The announcement has prompted a critical reevaluation of the company’s near-term prospects.

Guidance Shock Triggers Sell-Off

The catalyst for the recent sharp decline was the earnings report released on September 4. While the company managed to surpass analyst profit expectations for the quarter, this achievement was entirely overshadowed by a severe cut to its annual forecast. Management slashed its 2025 revenue outlook by approximately $300 million. More dramatically, its earnings per share guidance was reduced by nearly $2.

This disappointing revision is attributed to a confluence of factors. A noticeable softening in consumer demand within the U.S. market led to a 4% drop in comparable sales for the second quarter. Furthermore, the company is grappling with substantial tariff-related headwinds. CEO Calvin McDonald conceded that the brand’s casual product assortment had become “too predictable” and was failing to resonate with shoppers. The increased tariff burdens are projected to reduce the 2025 gross profit by a significant $240 million.

Market Experts Downgrade Ratings En Masse

The financial community’s response was swift and severe. Numerous prominent banks and research firms moved to downgrade their recommendations and price targets for the stock.

Should investors sell immediately? Or is it worth buying Lululemon?

Analysts at Telsey Advisory Group removed their “Outperform” rating and drastically reduced their target from $360 to $200. Wells Fargo analysts issued a new target of $160. William Blair similarly withdrew its “Outperform” assessment. In a contrasting move, Truist Securities maintained a “Buy” recommendation with a $290 price target, standing against the prevailing negative sentiment. The overall consensus, however, is clear: the collective rating from the 29 analysts covering Lululemon has now slipped to “Hold,” indicating widespread and persistent skepticism.

International Operations Provide a Silver Lining

Amid the gloom in North America, Lululemon’s international segment continues to be a notable bright spot. The company is anticipating robust growth of 20-25% in China for 2025, with other international markets expected to expand by roughly 20%. While this geographic diversification offers a partial buffer, it is currently insufficient to fully counterbalance the pronounced struggles in the U.S. and the financial impact of tariffs.

In response to these challenges, the management team has outlined a recovery strategy. A fundamental overhaul of the product portfolio is promised, with the proportion of new styles slated to increase from 23% to 35% by the spring of 2026. The company is counting on new innovations, such as its “Align No Line” pants, to reinvigorate consumer interest and drive a recovery.

The critical question remains whether these initiatives can successfully engineer a turnaround. Forthcoming quarterly results will be scrutinized for early signs that the new strategy is gaining traction or if the current downward trend is set to continue.

Ad

Lululemon Stock: Buy or Sell?! New Lululemon Analysis from December 10 delivers the answer:

The latest Lululemon figures speak for themselves: Urgent action needed for Lululemon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.

Lululemon: Buy or sell? Read more here...

Tags: Lululemon
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Fiserv Stock
Analysis

Fiserv Leadership Bets Millions as Stock Languishes Near Lows

December 10, 2025
Xunlei Stock
Analysis

Xunlei’s Financial Results Present a Complex Investment Picture

December 10, 2025
Amazon Stock
Analysis

Amazon Bets Billions on India to Fuel Future Growth

December 10, 2025
Next Post
Lexicon Stock

Lexicon Pharmaceuticals Nears Critical Regulatory Milestone

Skyworks Stock

Leadership Shift at Skyworks Solutions Sparks Investor Interest

Cisco Stock

Cisco's AI Infrastructure Push: Strategic Moves and Market Implications

Recommended

Hims & Hers Stock

Regulatory Headwinds Challenge Hims & Hers’ Growth Trajectory

3 weeks ago
Absci Stock

Absci’s Financial Crossroads: Can Pipeline Progress Offset Mounting Losses?

3 weeks ago
Intel Stock

Intel’s Government Bailout: A High-Stakes Gamble

3 months ago
Alibaba Stock

Alibaba’s AI Investment Surge Ignites Stock Rally

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Amazon Bets Billions on India to Fuel Future Growth

Alibaba Shares Face Analyst Scrutiny Amid Diverging Views

The AI Boom Reshapes a Core Global ETF

Generac Shares Gain Favor on Data Center Growth Prospects

Gold Mining Stocks Surge as ETF Captures Sector Momentum

DroneShield Shares Plummet Amid Governance Concerns

Trending

Fiserv Stock
Analysis

Fiserv Leadership Bets Millions as Stock Languishes Near Lows

by Felix Baarz
December 10, 2025
0

Shares of financial technology provider Fiserv find themselves at a crossroads in December 2025, caught between significant...

Xunlei Stock

Xunlei’s Financial Results Present a Complex Investment Picture

December 10, 2025
Akero Therapeutics Stock

Akero Therapeutics Acquisition Finalized, Shares Delisted from Nasdaq

December 10, 2025
Amazon Stock

Amazon Bets Billions on India to Fuel Future Growth

December 10, 2025
Alibaba Stock

Alibaba Shares Face Analyst Scrutiny Amid Diverging Views

December 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Fiserv Leadership Bets Millions as Stock Languishes Near Lows
  • Xunlei’s Financial Results Present a Complex Investment Picture
  • Akero Therapeutics Acquisition Finalized, Shares Delisted from Nasdaq

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com